If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
65.40    0.40 (0.62%)
Bid:
64.20
Ask:
66.80
Spread: 2.60 (4.05%)
Market Cap: £112.42m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Proposed C Share Issue

5 Jan 2017 13:48

RNS Number : 4665T
GCP Asset Backed Income Fund Ltd
05 January 2017
 

GCP Asset Backed Income Fund Limited (the "Company" or "GCP Asset Backed Income")

Proposed C Share issue

On 8 November 2016 GCP Asset Backed Income announced the results of a substantially oversubscribed placing of ordinary shares in November 2016, raising gross proceeds of c.£15.6 million (the "Placing"). The net proceeds of the Placing have now been substantially invested or committed for investment.

In light of the attractive pipeline of investment opportunities identified by the Investment Manager, Gravis Capital Partners LLP, in the near term, and the premium rating of its shares in the secondary market, the Board of GCP Asset Backed Income is considering increasing the Company's capital base through a pre-emptive offer of c shares at a price of 100 pence per c share and targeting gross proceeds of £100 million (the "Issue").

The Issue is expected to broaden the Company's investor base, improve secondary market liquidity for shareholders, reduce its ongoing charges ratio per ordinary share by providing a larger equity base over which its fixed costs are spread and further diversify its portfolio of investments.

The Company is taking legal, tax and financial advice and will make a further announcement in due course.

Any issue of c shares will be subject to the approval of a prospectus in connection with the Issue by the UK Listing Authority.

Expected timetable:

+44 (0)20 7518 1490

Publication of Prospectus in connection with the Issue

late January 2017

Issue close and Admission

mid February 2017

This announcement contains Inside Information as defined under the Market Abuse Regulation (EU) No. 596/2014.

For further information, please contact:

Gravis Capital Partners LLP

+44 (0)20 7518 1490

David Conlon

david.conlon@gcpuk.com

Philip Kent

 

Dion Di Miceli

philip.kent@gcpuk.com

 

dion.dimiceli@gcpuk.com

Cenkos Securities plc

+44 (0)20 7397 8900

Tom Scrivens

tscrivens@cenkos.com

Oliver Packard

opackard@cenkos.com

Sapna Shah

sshah@cenkos.com

Buchanan

+44 (0)20 7466 5000

Charles Ryland

charlesr@buchanan.uk.com

Victoria Hayns

victoriah@buchanan.uk.com

 

Notes to Editors

The Company

GCP Asset Backed Income is a closed ended investment company traded on the London Stock Exchange's main market for listed securities. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective through a diversified portfolio of investments secured against contracted, predictable medium to long term cash flows and/or physical assets which are predominantly UK based

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKPDQNBKDADK
Date   Source Headline
10th Sep 20207:00 amRNSHalf-Yearly Report & Financial Statements
31st Jul 20207:00 amRNSInvestor Report as at 30 June 2020
23rd Jul 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
15th Jul 20204:42 pmRNSSecond Price Monitoring Extn
15th Jul 20204:38 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSNet Asset Value and Investment Update
10th Jul 20207:00 amRNSExtension to term of Revolving Credit Facility
7th Jul 20204:22 pmRNSResult of AGM & EGM
17th Jun 20204:36 pmRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
26th May 20207:00 amRNSTransaction in Own Shares
22nd May 20207:00 amRNSTransaction in Own Shares
20th May 20204:41 pmRNSSecond Price Monitoring Extn
20th May 20204:37 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSNotices of AGM & EGM
4th May 20207:00 amRNSInvestor Report as at 31 March 2020
29th Apr 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
21st Apr 20207:00 amRNSNet Asset Value and Investment Update
7th Apr 20207:00 amRNSAnnual Report & AGM
31st Mar 20207:00 amRNSTotal Voting Rights
25th Mar 20207:00 amRNSTransaction in Own Shares
24th Mar 20207:00 amRNSTransaction in Own Shares
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20207:00 amRNSAnnual Report & Financial Statements
19th Mar 20207:00 amRNSTransaction in Own Shares
18th Mar 20207:00 amRNSCompliance with Market Abuse Regulation
28th Feb 20209:47 amRNSTotal Voting Rights & Additional Listing
21st Feb 20207:00 amRNSAdditional Listing
17th Feb 20207:00 amRNSInvestment in co-living
6th Feb 20207:00 amRNSScrip Share Reference Price
30th Jan 20207:00 amRNSInvestor report as at 31 December 2019
29th Jan 20207:00 amRNSChange of corporate adviser
22nd Jan 20207:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Jan 20207:00 amRNSNet Asset Value
16th Jan 20207:00 amRNSRevolving Credit Facility
29th Nov 20199:34 amRNSTotal Voting Rights and Additional Listing
25th Nov 20197:00 amRNSAdditional Listing
7th Nov 201910:08 amRNSScrip Share Reference Price
7th Nov 20197:00 amRNSDirectorate Change
31st Oct 20197:00 amRNSInvestor Report as at 30 September 2019
23rd Oct 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Oct 20197:00 amRNSSpecial dividend declaration
15th Oct 20197:00 amRNSNet Asset Value(s)
30th Sep 20197:00 amRNSTotal Voting Rights
10th Sep 20197:00 amRNSHalf-Yearly Report & Financial Statements
2nd Sep 201910:01 amRNSTotal Voting Rights & Additional Listing
22nd Aug 20197:00 amRNSAdditional Listing
8th Aug 20197:00 amRNSScrip Share Reference Price
2nd Aug 20197:00 amRNSInvestor Report as at 30 June 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.